Effectiveness of chemotherapy in measurable granulosa cell tumors: A retrospective study and review of literature

International Journal of Gynecological Cancer

Volumn 24, Issue 3, 2014, Pages 496-505

  Van Meurs, Hannah S ^a   Buist, Marrije R ^a   Westermann, Anneke M ^a   Sonke, Gabe S ^b,c   Kenter, Gemma G ^a   Van Der Velden, Jacobus ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Integraal Kankercentrum Amsterdam   (Netherlands)

Author keywords

Chemotherapy; Granulosa cell tumor; Sex cordYstromal tumor; Treatment

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT REFERRAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL TIME; THECOMA; TREATMENT RESPONSE; MIDDLE AGED; OVARIAN NEOPLASMS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; GRANULOSA CELL TUMOR; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINBLASTINE;

EID: 84900416259     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000077     Document Type: Article

References (36)

1. Busby T, Anderson GW. Feminizing mesenchymomas of the ovary; includes 107 cases of granulosa-, granulosa-theca-cell, and theca-cell tumors. Am J Obstet Gynecol. 1954;68:1391-1420.
2. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180-1189.
3. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol. 1981;11:261-274.
4. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol. 1979;7:136-152.
5. van Meurs HS, Bleeker MCG, van der Velden J, et al. The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long term follow-up in a population based cohort study. Int J Gynecol Cancer. 2013;23:1417-1422.
6. Peiretti M, Colombo N. Sex Cord-Stromal Tumors of the Ovary. In: Ayhan A, Reed N, Gultekin M, et al. eds. Textbook of Gynaecological Oncology Gunes Publishing. 2012:477-480.
7. ClinicalTrials.gov. A service of the U.S. National Institutes of Health. Available at: http://clinicaltrials.gov/ct2/show/NCT01042522. Accessed August 15, 2013.
8. Homesley HD, Bundy BN, Hurteau JA, et al. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;72:131-137.
9. Al-Badawi IA, Brasher PM, Ghatage P, et al. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2002;12:119-123.
10. Camlibel FT, Caputo TA. Chemotherapy of granulosa cell tumors. Am J Obstet Gynecol. 1983;145:763-765.
11. Chiara S, Merlini L, Campora E, et al. Cisplatin-based chemotherapy in recurrent or high risk ovarian granulosa-cell tumor patients. Eur J Gynaecol Oncol. 1993;14:314-317.
12. Colombo N, Sessa C, Landoni F, et al. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol. 1986;67:265-268.
13. Erdreich-Epstein A, Monforte HL, Lavey RS, et al. Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary. J Pediatr Hematol Oncol. 2002;24:229-233.
14. Gershenson DM, Morris M, Burke TW, et al. Treatment of poor-prognosis sex cordYstromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996;87:527-531.
15. Jacobs AJ, Deppe G, Cohen CJ. Combination chemotherapy of ovarian granulosa cell tumor with cis-platinum and doxorubicin. Gynecol Oncol. 1982;14:294-297.
16. Kaye SB, Davies E. Cyclophosphamide, adriamycin, and cis-platinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker. Gynecol Oncol. 1986;24:261-264.
17. Malkasian GD Jr, Webb MJ, Jorgensen EO. Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. Obstet Gynecol. 1974;44:885-888.
18. Muntz HG, Goff BA, Fuller AF Jr. Recurrent ovarian granulosa cell tumor: role of combination chemotherapy with report of a long-term response to a cyclophosphamide, doxorubicin and cisplatin regimen. Eur J Gynaecol Oncol. 1990;11:263-268.
19. Neville AJ, Gilchrist KW, Davis TE. The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center. Med Pediatr Oncol. 1984;12:397-400.
20. Nosov V, Silva I, Tavassoli F, et al. Predictors of recurrence of ovarian granulosa cell tumors. Int J Gynecol Cancer. 2009;19:628-633.
21. Ohara N, Teramoto K, Murao S. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma. J Obstet Gynaecol. 2002;22:573-574.
22. Pautier P, Gutierrez-Bonnaire M, Rey A, et al. Combination of bleomycin, etoposide, and cisplatin for the treatment ofadvanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2008;18:446-452.
23. Pecorelli S, Wagenaar HC, Vergote IB, et al. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study. Eur J Cancer. 1999;35:1331-1337.
24. Pectasides D, Alevizakos N, Athanassiou AE. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary. Ann Oncol. 1992;3: 316-318.
25. Pectasides D, Papaxoinis G, Fountzilas G, et al. Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res. 2008;28:1421-1427.
26. Ranganath R, Sridevi V, Shirley SS, et al. Clinical and pathologic prognostic factors in adult granulosa cell tumors of the ovary. Int J Gynecol Cancer. 2008;18:929-933.
27. Savage P, Constenla D, Fisher C, et al. Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clin Oncol (R Coll Radiol). 1998;10:242-245.
28. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol. 1976;125:402-411.
29. Uygun K, Aydiner A, Saip P, et al. Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 2003;88:400-403.
30. Uygun K, Aydiner A, Saip P, et al. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol. 2003;26:517-521.
31. Zambetti M, Escobedo A, Pilotti S, et al. cis-platinum/vinblastine/ bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol. 1990;36:317-320.
32. Brown J, Shvartsman HS, Deavers MT, et al. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cordYstromal ovarian tumors. Gynecol Oncol. 2005;97:489-496.
33. Eisenhauer EA, Therasse P, Bogaerts J, et al. New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-247.
34. Gershenson DM, Copeland LJ, Kavanagh JJ, et al. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1987;70:765-769.
35. Korach J, Perri T, Beiner M, et al. Promising effect of aromatase inhibitors on recurrent granulosa cell tumors. Int J Gynecol Cancer. 2009;19:830-833.
36. Tao X, Sood AK, Deavers MT, et al. Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecol Oncol. 2009; 114:431-436.